![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Exicure Inc is a clinical-stage biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA ... Exicure Inc is a clinical-stage biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology. Show more
Exicure, Inc. (Nasdaq: XCUR, the βCompanyβ), has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated...
Period β | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0224 | -6.18272150152 | 0.3623 | 0.3623 | 0.3003 | 109797 | 0.32396918 | CS |
4 | -0.139 | -29.0248486114 | 0.4789 | 0.8549 | 0.3 | 985661 | 0.46265265 | CS |
12 | -0.2601 | -43.35 | 0.6 | 0.8549 | 0.3 | 332012 | 0.46971975 | CS |
26 | -0.3301 | -49.2686567164 | 0.67 | 0.86 | 0.3 | 391007 | 0.60380915 | CS |
52 | -0.8101 | -70.4434782609 | 1.15 | 1.5 | 0.3 | 337216 | 0.58470044 | CS |
156 | -1.2901 | -79.1472392638 | 1.63 | 3.24 | 0.0846 | 2631752 | 0.36294019 | CS |
260 | -1.8601 | -84.55 | 2.2 | 3.84 | 0.0846 | 1745867 | 0.51656398 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions